Quest Diagnostics EBITDA 2010-2024 | DGX

Quest Diagnostics annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Quest Diagnostics EBITDA for the quarter ending September 30, 2024 was $0.455B, a 0.44% increase year-over-year.
  • Quest Diagnostics EBITDA for the twelve months ending September 30, 2024 was $1.719B, a 9.07% increase year-over-year.
  • Quest Diagnostics 2023 annual EBITDA was $1.701B, a 8.79% decline from 2022.
  • Quest Diagnostics 2022 annual EBITDA was $1.865B, a 33.13% decline from 2021.
  • Quest Diagnostics 2021 annual EBITDA was $2.789B, a 19.6% increase from 2020.
Quest Diagnostics Annual EBITDA
(Millions of US $)
2023 $1,701
2022 $1,865
2021 $2,789
2020 $2,332
2019 $1,560
2018 $1,410
2017 $1,435
2016 $1,526
2015 $1,703
2014 $1,297
2013 $1,758
2012 $1,488
2011 $1,268
2010 $1,538
2009 $1,616
Quest Diagnostics Quarterly EBITDA
(Millions of US $)
2024-09-30 $455
2024-06-30 $472
2024-03-31 $416
2023-12-31 $376
2023-09-30 $453
2023-06-30 $460
2023-03-31 $412
2022-12-31 $251
2022-09-30 $500
2022-06-30 $495
2022-03-31 $619
2021-12-31 $642
2021-09-30 $753
2021-06-30 $633
2021-03-31 $761
2020-12-31 $893
2020-09-30 $807
2020-06-30 $372
2020-03-31 $260
2019-12-31 $445
2019-09-30 $395
2019-06-30 $388
2019-03-31 $332
2018-12-31 $301
2018-09-30 $381
2018-06-30 $382
2018-03-31 $346
2017-12-31 $342
2017-09-30 $367
2017-06-30 $385
2017-03-31 $341
2016-12-31 $339
2016-09-30 $385
2016-06-30 $483
2016-03-31 $319
2015-12-31 $313
2015-09-30 $708
2015-06-30 $376
2015-03-31 $306
2014-12-31 $336
2014-09-30 $335
2014-06-30 $343
2014-03-31 $283
2013-12-31 $342
2013-09-30 $758
2013-06-30 $361
2013-03-31 $297
2012-12-31 $337
2012-09-30 $376
2012-06-30 $405
2012-03-31 $370
2011-12-31 $389
2011-09-30 $395
2011-06-30 $390
2011-03-31 $94
2010-12-31 $346
2010-09-30 $401
2010-06-30 $429
2010-03-31 $362
2009-12-31 $393
2009-09-30 $412
2009-06-30 $425
2009-03-31 $386
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.988B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00